CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Bajaj Healthcare Ltd

Bajaj Healthcare Ltd

BSE 539872 BAJAJHCARE INE411U01027
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

21 filings · 6 material · busiest 2026-07-20

What it files

General4 Analyst / Investor Meet3 ESOP Allotment1 Credit Rating1 Concall Transcript1 Newspaper Publication1 Board Outcome1 Results1

Filings

21 in the window

  1. 21 August 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    Intimation of allotment of equity shares pursuant to exercise of ESOPs

    Company Update / Allotment of ESOP / ESPS View filing →

  2. 12 August 2026

    General

    Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    The Company has received the approval from DCGI to manufacture and market Cenobamate API and Tablets

    Company Update / General View filing →

  3. 6 August 2026

    Credit Rating

    Credit Rating

    Revision in Credit Rating

    Company Update / Credit Rating View filing →

  4. 27 July 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript of Earnings Call for Q1FY27

    Company Update / Earnings Call Transcript View filing →

  5. 22 July 2026

    Newspaper Publication

    Newspaper Publication

    Intimation for Newspaper Publication

    Company Update / Newspaper Publication View filing →

  6. 21 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Intimation for Audio Recording of Earnings Call for Q1FY27

    Company Update / Analyst / Investor Meet View filing →

  7. 20 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting

    Outcome of the Board Meeting held on July 20, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  8. 20 July 2026

    Results

    Results-Financial Results For June 30, 2026

    Financial Results for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  9. 20 July 2026

    Change in Management

    Change in Management

    Continuation of directorship of Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director of the Company upon attaining the age of 75 years

    Company Update / Change in Management View filing →

  10. 20 July 2026

    Monitoring Agency

    Monitoring Agency Report

    Monitoring Agency Report for the quarter ended June 30, 2026

    Company Update / Monitoring Agency Report View filing →

  11. 20 July 2026

    Other Update

    Compliances- Statement Of Deviation & Variation

    Statement of Deviation & Variation for the quarter ended June 30, 2026

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  12. 20 July 2026

    Press Release

    Press Release / Media Release

    Press Release for the quarter ended June 30, 2026

    Company Update / Press Release / Media Release View filing →

  13. 20 July 2026

    General

    Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    Intimation for Grant of Employee Stock Options under Bajaj Healthcare Limited Employee Stock Option Plan 2024

    Company Update / General View filing →

  14. 16 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Earnings Call Invite

    Company Update / Analyst / Investor Meet View filing →

  15. 16 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Earnings Call Invite

    Company Update / Analyst / Investor Meet View filing →

  16. 14 July 2026

    Board Meeting

    Board Meeting Intimation for Consideration Of Financial Results

    Bajaj Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....

    Board Meeting / Board Meeting View filing →

  17. 8 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under Regulation 74(5) of SEBI (DP), Regulations, 2018 for the quarter ended June 30, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  18. 26 June 2026

    General

    Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    The Company has received a recommendation from SEC-CDSCO to manufacture and market Cenobamate Tablets

    Company Update / General View filing →

  19. 24 June 2026

    Trading Window

    Closure of Trading Window

    Intimation for closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  20. 23 June 2026

    General

    Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

    Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for the sale of a business unit of the Company

    Company Update / General View filing →

  21. 15 June 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anil Jain

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →